NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)

Al's Comment:

 This should allow for the more complete removal of these tumors!


Posted on: 11/19/2020 [Click the link below for full article]

NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)

 


Click HERE to return to brain tumor news headlines.